From Surf Wiki (app.surf) — the open knowledge base
Hydrastine
Chemical compound
Chemical compound
| elimination_half-life =
Hydrastine is an isoquinoline alkaloid which was discovered in 1851 by Alfred P. Durand. Nitric acid induced hydrolysis of hydrastine yields hydrastinine, which was patented by Bayer as a haemostatic drug in the early 1900s. It is present in Hydrastis canadensis (thus the name) and other plants of the family Ranunculaceae.
Total synthesis
The first attempt for the total synthesis of hydrastine was reported by Sir Robert Robinson and co-workers in 1931. Following studies where the synthesis of the key lactonic amide intermediate (structure 4 in figure) was the most troublesome, the major breakthrough was achieved in 1981 when J. R. Falck and co-workers reported a four-step total synthesis of hydrastine from simple starting materials. The key step in the Falck synthesis was using a Passerini reaction to construct the lactonic amide intermediate 4. :[[File:Falck’s total synthesis of hydrastine, the mechanism of the Passerini reaction for synthesis of the key intermediate is also illustrated.png|class=skin-invert-image|Falck’s total synthesis of hydrastine, the mechanism of the Passerini reaction for synthesis of the key intermediate is also illustrated]] Starting from a simple phenylbromide variant 1, alkylation reaction with lithium methylisocyanide gives the isocyanide intermediate 2. Reacting isocyanide intermediate 2 with opianic acid 3 initiated the intramolecular Passerini reaction to give the key lactonic amide intermediate 4. The tetrahydro-isoquinolin ring was formed by first a ring-closure reaction under dehydration conditions using POCl3 and then a catalyzed hydrogenation using PtO2 as the catalyst. Finally, hydrastine was synthesized by installing the N-methyl group via reductive amination reaction with formaldehyde.
Biological action
Hydrastine acts as a convulsant in mice. It appears to do this by binding to bicuculline-sensitive GABAA receptors as a potent competitive antagonist. The action appears to be largely mediated by the (+) enantiomer (IC50 of 0.4µM), as (-)-hydrastine is 180 times less potent in regards to this effect.
References
References
- (July 1862). "On Hydrastine, an Alkaloid Occurring in Hydrastis Canadensis.". J. Churchill.
- (2006). "Römpp CD". Georg Thieme Verlag.
- (1931). "XXXI.—A synthesis of hydrastine. Part I". J. Chem. Soc..
- (1950). "Synthesis of Hydrastine". Nature.
- (1950). "360. A new route to the phthalide-isoquinoline bases, and a synthesis of (–)-hydrastine". J. Chem. Soc..
- (1981). "An intramolecular passerini reaction: Synthesis of hydrastine.". Tetrahedron Letters.
- Huang, J. H.. (April 1990). "(+)-Hydrastine, a potent competitive antagonist at mammalian GABAA receptors". British Journal of Pharmacology.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Hydrastine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report